Brief: Lyra Therapeutics Announces First Patient Enrolled In Pivotal Enlighten Ii Clinical Trial Of Lyr-210 In Chronic Rhinosinusitis Patients

Lyra Therapeutics

08/09/2022 13:44

Sept 8 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN
PIVOTAL
ENLIGHTEN II CLINICAL TRIAL OF LYR-210 IN CHRONIC RHINOSINUSITIS
PATIENTS

Source text for Eikon:  ID:nPn5jm94La 
Further company coverage:  LYRA.O 

 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))